Fig. 2
From: Knockdown of ATRX enhances radiosensitivity in glioblastoma
Kaplan-Meier analysis and log-rank test of overall survival between ATRX mutation and wild-type group. A Patients with an ATRX mutation exhibited a significantly prolonged survival time compared with patients with the ATRX wild-type gene (P = 0.003). B Patients with an ATRX deletion exhibited a significantly prolonged survival time compared with patients with the ATRX wild-type gene (P = 0.007). No significant differences were observed in patients with ATRX SNPs compared with patients with the ATRX wild-type gene (P = 0.113). ATRX, alpha-thalassemia X-linked mutant retardation syndrome; SNP, single-nucleotide polymorphism